Philip Bejon
Director Modernising Medical Microbiology
I was Director of the KEMRI-Wellcome Trust Research Programme up to January 2024, and was based in Kenya for 10 years. I am now based in Oxford, as Director of the Modernising Medical Microbiology Unit, where I work on antimicrobial resistance, bone infection, and pathogen genomics. I continue to work with colleagues based in Kenya on controlled human malaria infection studies, and on evaluations of malaria vaccines in the field, on validating definitions of severe malaria, studies of naturally acquired immunity to malaria, evaluations of Ebola and Yellow Fever vaccines, and on the epidemiology and immunology of COVID in Kenya.
Visit Philip's profile page for Modernising Medical Microbiology
Recent publications
-
Rethinking the evidence on COVID-19 in Africa.
Bejon P. et al, (2025), The Lancet. Infectious diseases
-
Nanopore adaptive sampling for bacterial identification from periprosthetic joint replacement tissue
Street TL. et al, (2025)
-
Low-Dose Yellow Fever Vaccine in Adults in Africa
Kimathi D. et al, (2025), New England Journal of Medicine, 392, 788 - 797
-
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
Kimotho J. et al, (2024), Wellcome Open Research, 8, 350 - 350
-
Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysis.
Miotto O. et al, (2024), The Lancet. Microbe